-
1 Comment
DarioHealth Corp is currently in a long term uptrend where the price is trading 2.8% above its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 16.0.
DarioHealth Corp's total revenue rose by 15.7% to $2M since the same quarter in the previous year.
Its net income has dropped by 115.6% to $-9M since the same quarter in the previous year.
Finally, its free cash flow fell by 137.2% to $-7M since the same quarter in the previous year.
Based on the above factors, DarioHealth Corp gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Health Information Services |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | US23725P2092 |
| Target Price | 2.3333 |
|---|---|
| Beta | 1.56 |
| Market Cap | 33M |
| PE Ratio | None |
| Dividend Yield | None |
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for DRIO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
